Matches in Nanopublications for { ?s ?p "[Our results suggest that the PSMA peptide LLHETDSAV is poorly immunogenic in humans and that alternative prostate cancer antigens should be pursued.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine."@en ?g. }
Showing items 1 to 4 of
4
with 100 items per page.
- assertion description "[Our results suggest that the PSMA peptide LLHETDSAV is poorly immunogenic in humans and that alternative prostate cancer antigens should be pursued.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- assertion description "[Our results suggest that the PSMA peptide LLHETDSAV is poorly immunogenic in humans and that alternative prostate cancer antigens should be pursued.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." provenance.
- NP699328.RAUK-BNPKj7pAC2_kRihu0GJYPXJlb3VzpiHxL1nl9xqo130_assertion description "[Our results suggest that the PSMA peptide LLHETDSAV is poorly immunogenic in humans and that alternative prostate cancer antigens should be pursued.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699328.RAUK-BNPKj7pAC2_kRihu0GJYPXJlb3VzpiHxL1nl9xqo130_provenance.
- NP699327.RAjrCf8xbDgjP9nAL-PdGf9CqCDukJiT7AZgVGabjvPfc130_assertion description "[Our results suggest that the PSMA peptide LLHETDSAV is poorly immunogenic in humans and that alternative prostate cancer antigens should be pursued.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP699327.RAjrCf8xbDgjP9nAL-PdGf9CqCDukJiT7AZgVGabjvPfc130_provenance.